805
Views
2
CrossRef citations to date
0
Altmetric
Licensed Vaccines – Research Paper

Mumps serological surveillance following 10 years of a one-dose mumps-containing-vaccine policy in Fujian Province, China

, , , , , , , & show all
Article: 2096375 | Received 05 May 2022, Accepted 28 Jun 2022, Published online: 11 Aug 2022

References

  • Liu Y, Hu Y, Deng X, Wang Z, Lu P, Ma F, Zhou M, Liu P, Min J. Seroepidemiology of mumps in the general population of Jiangsu province, China after introduction of a one-dose measles-mumps-rubella vaccine. Sci Rep. 2015;5(14660). doi:10.1038/srep14660.
  • Su SB, Chang HL, Chen KT. Current status of mumps virus infection: epidemiology, pathogenesis, and vaccine. Int J Mol Sci. 2020;17:1. doi:10.3390/ijerph17051686.
  • Cui A, Zhu Z, Hu Y, Deng X, Sun Z, Zhang Y, Mao N, Xu S, Fang X, Gao H, et al. Mumps epidemiology and mumps virus genotypes circulating in mainland China during 2013-2015. Plos One. 2017. doi:10.1371/journal.pone.0169561.
  • Cui A, Zhu Z, Chen M, Zheng H, Liu L, Wang Y, Ma Y, Wang C, Fang X, Li P, et al. Epidemiologic and genetic characteristics of mumps viruses isolated in China from 1995 to 2010. Infect Genet Evoln. 2014;21:384–7. doi:10.1016/j.meegid.2013.1012.1005.
  • Hviid A, Rubin S. Mühlemann K. Mumps. Lancet. 2008;371(9616):932–944. doi:10.1016/S0140-6736(1008)60419-60415.
  • Sasaki H, Fukunaga T, Asano A, Yamanaka K, Oikawa K, Shibata N. Seroprevalence of anti-mumps virus IgG antibody titer and voluntary mumps vaccination coverage in young adults in Japan. Hum Vaccin Immunother. 2021;17(9):3153–3155. doi:10.1080/21645515.2021.1913967.
  • Li R, Cheng S, Luo C, Rutherford S, Cao J, Xu Q, Liu X, Liu Y, Xue F, Xu Q, et al. Epidemiological characteristics and spatial-temporal clusters of Mumps in Shandong Province, China, 2005–2014. Scientific Reports. 2017: 7:46328doi: 10.46310.41038/srep46328.
  • Dong L, Zhifei C, Xiuhui Y, Weiyi P, Qin W, Suhan Z, Ningxuan Z, Lifang H, Yong Z. Epidemiological and pathogenic characteristics of mumps in Fujian province, 2005-2017. Zhong Hua Liu Xing Bing Xue Za Zhi [Chinese Journal of Epidemiology]. 2018;39(10):1356. doi:10.3760/cma.j.issn.0254-6450.2018.10.013.
  • Xiuhui Y, Huiri G, Yanyan S, Aihua H, Hongrong Z, Jiangyan X. Genetic characterization of the mumps virus isolated from an outbreak in Fujian. Chinese J Vaccines Immun. 2013;19:43–46.
  • Dong L, Xiuhui Y, Zhifei C, Suhan Z, Ningxuan Z, Hongrong Z, and Yong Z. Pathogenic characteristics of mumps virus isolated from an outbreak in Fujian Province, 2015. Chinese J Vaccines Immun. 2016;22(05):519-524-.
  • Dong L, Zhifei C, Danhong C, Weiyi P, Yong Z, Hairong Z, Suhan Z, Ningxuan Z, Xiuhui Y. Etiological identification and genetic characteristics of a mumps outbreak in Fujian province, 2018. Chinese J Vaccines Immun. 2018;24:526–530.
  • Hamami D, Cameron R, Kg P, Shankland C. Waning immunity is associated with periodic large outbreaks of mumps: a mathematical modeling study of Scottish Data. Front Physiol. 2017;8(233). doi:10.3389/fphys.2017.00233.
  • Lewnard J, Grad Y. Vaccine waning and mumps re-emergence in the United States. Sci Transl Med. 2018;10(433):eaao5945. doi:10.1126/scitranslmed.aao5945.
  • Pang H, Zhou Y, Zhao W, Jiang Q. Seroprevalence and determinants associated with mumps antibodies after 20 years of MMR vaccination in urban area of Shanghai, China. Int J Environ Res Public Health. 2018;15(10):2089. doi:10.3390/ijerph15102089.
  • Rm A, Rm M. Vaccination and herd immunity to infectious diseases. Nature. 1985; 318(6044):323–329. https://wwwnature.53yu.com/articles/318323a0.
  • Pang H, Zhou Y, Zhao W, Jiang Q. Epidemiological changes in mumps infections between 1990 and 2017 in urban area of Shanghai, China. Hum Vaccin Immunother. 2021;17(5):1358–1365. doi:10.1080/21645515.2020.1827610.
  • Wang Q, Cheng X, Liu D, Chen C, Yao K. One single-center serological survey on measles, rubella and mumps antibody levels of people in Youyang, China. Hum Vaccin Immunother. 2021;17(11):4203–4209. doi:10.1080/21645515.2021.1924522.
  • Waaijenborg S, Sjm H, Mollema L, Smits GP, Berbers GAM, Frmvd K, Hed M, Wallinga J. Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage. J Infect Dis. 2013;208(1):10–16. doi:10.1093/infdis/jit143.
  • Smits G, Mollema L, Hahne S, Hd M, Tcherniaeva I, Waaijenborg S, Rv B, Klis FVD, Berbers G. Seroprevalence of mumps in The Netherlands: dynamics over a decade with high vaccination coverage and recent outbreaks. Plos One. 2013;8(3):e58234. doi:10.1371/journal.pone.0058234.
  • National Health Commission of the People’s Republic of China. Adjustment on immune procedure of poliomyelitis vaccine and measles-containing vaccine 2020. [accessed 2022 Apr 2022]. http://www.nhc.gov.cn/jkj/s3590/202001/f1b793e053ea49d3b4251fe107ada325.shtml.
  • HuaiHo Y, ChiTsai C, WenTsai Y, ChiangWang Y, YienLin T, JenLee D, JungChen C. Humoral immunity to mumps in a highly vaccinated population in Taiwan. J Microbiol Immunol Infect. 2019;52(3):379–385. doi:10.1016/j.jmii.2017.09.001.
  • Sun X, Tang F, Hu Y, Deng X, Wang Z, Zhou M, Liu Y. High risk of mumps infection in children who received one dose of mumps-containing vaccine: waning immunity to mumps in children aged 2-5 years from kindergartens in Jiangsu Province, China. Human Vaccines Immunotherapeutics. 2020;16(7):1738–1742. doi:10.1080/21645515.2019.1708162.
  • Mossong J, Putz L, Schneider F. Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study. Epidemiol Infect. 2004;132(1):11–18. doi:10.1017/S0950268803001584.
  • Kristina B, Abreu E, Arneborn M, Böttiger M. Immunity to mumps before and after MMR vaccination at 12 years of age in the first generation offered the two-dose immunization programme. Vaccine. 1998;16(2–3):323–327. doi:10.1016/S0264-410X(97)88332-6.
  • Ferrari C, Aurilio MT, Mazza A, Pietroiusti A, Magrini A, Balbi O, Bolcato M, Coppeta L. Evaluation of immunity for mumps among vaccinated medical students. Vaccines. 2021;9(599). doi:10.3390/vaccines9060599.
  • Su QR, Liu J, Ma C, Fan CX, Wen N, Luo HM, Wang HQ, Li L, Hao LX. Epidemic profile of mumps in China during 2004-2013. Zhonghua Yu Fang Yi Xue Za Zhi. 2016;6(50):611–614. doi:10.3760/cma.j.issn.0253-9624.2016.07.009.
  • Angela D, Núria T, Jesús C, Joan B, Pere G, Marcela G, Dolors C, Joan C, Cristina R, Maria J. Mumps vaccine effectiveness in highly immunized populations. Vaccine. 2010;28(20):3567–3570. doi:10.1016/j.vaccine.2010.02.107.
  • WHO. Mumps virus vaccines. Wkly Epidemiol Rec. 2007;82(7):51–60. Available online.
  • Scepanovic P, Alanio C, Hammer C, Hodel F, Bergstedt J, Patin E, Thorball CW, Chaturvedi N, Charbit B, Abel L, et al. Human genetic variants and age are the strongest predictors of humoral immune responses to common pathogens and vaccines. Genome Med. 2018;10(59). doi:10.1186/s13073-13018-10568-13078.
  • Lklein S, Jedlicka A, Pekosz A. The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis. 2010;10(11):338–349. doi:10.1016/S1473-3099(10)70049-9.
  • Meng Q, Liu Y, Yu J, Li L, Shi W, Shen Y, Li L, Zhan S, Yang F, Wang Y, et al. Seroprevalence of maternal and cord antibodies specific for diphtheria, tetanus, pertussis, measles, mumps and rubella in Shunyi, Beijing. Sci Rep. 2018;8(1):13021. doi:10.1038/s41598-018-31283-y.
  • Katie G, Jane W, Ewout F, Marjon B, Koen H, Kioe B, Corien S, Tjibbe D, Binnendijk R, Melker H, et al. Mumps outbreak among vaccinated university students associated with a large party, the Netherlands, 2010. Vaccine. 2012;30(29):4676–4680. doi:10.1016/j.vaccine.2012.04.083.
  • Rubin S, Link M, Sauder C, Zhang C, Ngo L, Rima B, Duprex W. Recent mumps outbreaks in vaccinated populations: no evidence of immune escape. J Virol. 2012;86(1):615–620. doi:10.1128/JVI.06125-11.
  • WHO. Mumps. Vaccine Position Papers. 2007 [accessed 2022 Mar 27]. http://www.who.int/immunization/documents/positionpapers/en.
  • Li YT, Luo XQ, Zhong XB, Cai LM, Zhu LP, Chen XQ, Wang KC, Chen ZG. Seroprevalences of antibodies against pertussis, diphtheria, tetanus, measles, mumps and rubella: A, cross-sectional study in children following vaccination procedure in Guangzhou, China. Vaccine. 2020;38(23):3960–3967. doi:10.1016/j.vaccine.2020.03.056.